BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9209310)

  • 1. SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine.
    Hayami M; Igarashi T
    Leukemia; 1997 Apr; 11 Suppl 3():95-7. PubMed ID: 9209310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use.
    Hayami M; Igarashi T; Kuwata T; Ui M; Haga T; Ami Y; Shinohara K; Honda M
    Leukemia; 1999 Apr; 13 Suppl 1():S42-7. PubMed ID: 10232364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
    Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
    Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
    J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach to AIDS research and prevention: the use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines.
    Haga T; Kuwata T; Ui M; Igarashi T; Miyazaki Y; Hayami M
    Microbiol Immunol; 1998; 42(4):245-51. PubMed ID: 9623910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus strain mac (SIVmac) and chimeric HIV-1/SIVmac viruses having env genes derived from macrophage-tropic viruses: an indication of different mechanisms of macrophage-tropism in human and monkey cells.
    Chen J; Ido E; Jin M; Kuwata T; Igarashi T; Mizuno A; Koyanagi Y; Hayami M
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():741-5. PubMed ID: 9568969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
    Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of a new simian/human immunodeficiency viruses clone carrying an env gene derived from a CRF07_BC strain.
    Li Y; Yang GB; Chen QM; Liu Q; Meng ZF; Geng YQ; Qiao WT; Shao YM
    Chin Med J (Engl); 2009 Dec; 122(23):2874-9. PubMed ID: 20092794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of macaques with chimeric simian and human immunodeficiency viruses containing Env from subtype F.
    Kuwata T; Takemura T; Takehisa J; Miura T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1121-32. PubMed ID: 12111423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
    Luciw PA; Mandell CP; Himathongkham S; Li J; Low TA; Schmidt KA; Shaw KE; Cheng-Mayer C
    Virology; 1999 Oct; 263(1):112-27. PubMed ID: 10544087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs.
    Ui M; Kuwata T; Igarashi T; Ibuki K; Miyazaki Y; Kozyrev IL; Enose Y; Shimada T; Uesaka H; Yamamoto H; Miura T; Hayami M
    Virology; 1999 Dec; 265(2):252-63. PubMed ID: 10600597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.
    Bogers WM; Niphuis H; ten Haaft P; Laman JD; Koornstra W; Heeney JL
    AIDS; 1995 Dec; 9(12):F13-8. PubMed ID: 8605046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta.
    Bogers WM; Dubbes R; ten Haaft P; Niphuis H; Cheng-Mayer C; Stahl-Hennig C; Hunsmann G; Kuwata T; Hayami M; Jones S; Ranjbar S; Almond N; Stott J; Rosenwirth B; Heeney JL
    Virology; 1997 Sep; 236(1):110-7. PubMed ID: 9299623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins.
    Li J; Lord CI; Haseltine W; Letvin NL; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1992; 5(7):639-46. PubMed ID: 1613662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys.
    Igarashi T; Shibata R; Hasebe F; Ami Y; Shinohara K; Komatsu T; Stahl-Hennig C; Petry H; Hunsmann G; Kuwata T
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):1021-9. PubMed ID: 7811533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
    Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High viral load and CD4 lymphopenia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env, rev, tat, and vpu genes from HIV-1 Lai.
    Dunn CS; Beyer C; Kieny MP; Gloeckler L; Schmitt D; Gut JP; Kirn A; Aubertin AM
    Virology; 1996 Sep; 223(2):351-61. PubMed ID: 8806570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.